Clinical Trial Update: Long-term Safety Study of Kineret® in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA)

View source ↗

Summary

This clinical trial update reports long-term safety data for anakinra (Kineret) in patients with systemic juvenile idiopathic arthritis (SJIA) from a completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Juvenile Idiopathic Arthritis

Drugs mentioned

• KINERET (ANAKINRA)

Snippet

Sponsor: Swedish Orphan Biovitrum | Conditions: Still Disease, Juvenile Onset | Status: COMPLETED